IANAD, but the early and ongoing successes of immunotherapy across a wide variety of cancers suggests that your characterization of this effort as "nonsensical"

IANAD, but the early and ongoing successes of immunotherapy across a wide variety of cancers suggests that your characterization of this effort as "nonsensical" is cynically oversimplified, if not wrong.